Second CGM receives Medicare approval

Tuesday, January 9, 2018

ABBOTT PARK, Ill. – The FreeStyle Libre System is the second continuous glucose monitoring system approved for Medicare coverage. The Abbott-manufactured system requires no user calibration, reading glucose levels via a sensor worn on the upper arm. Users simply wave a reader over the sensor to get a reading. CMS in early 2017 approved certain CGMs as DME as long as they are approved by the Food and Drug Administration for use in place of a blood glucose monitor for making treatment decisions. The first such system approved: the Dexcom 5.